<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>中康开思 | wechat-feeds</title><link>http://MzUyODM5NzU3Ng.favicon.privacyhide.com/favicon.ico</link><description>基于数据科学，提供高效便捷的健康产业数据情报，连接数据与决策。</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 19 Apr 2021 17:23:07 +0800</pubDate><image><url>http://MzUyODM5NzU3Ng.favicon.privacyhide.com/favicon.ico</url><title>中康开思 | wechat-feeds</title><link>http://MzUyODM5NzU3Ng.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>齐鲁安替制药受理号申报最多 | 药品审评进度周周看（4.12-4.18）</title><link>https://mp.weixin.qq.com/s/l8KegdPWCbYTk2YxiEwEhQ</link><description></description><content:encoded><![CDATA[齐鲁安替制药受理号申报最多 | 药品审评进度周周看（4.12-4.18）]]></content:encoded><pubDate>Mon, 19 Apr 2021 16:51:17 +0800</pubDate></item><item><title>君实生物新药受理号申报最多 | 药品审评进度周周看（4.5-4.11）</title><link>https://mp.weixin.qq.com/s/jRqPI_CUdIFGFbVOUdAgZQ</link><description></description><content:encoded><![CDATA[君实生物新药受理号申报最多 | 药品审评进度周周看（4.5-4.11）]]></content:encoded><pubDate>Mon, 12 Apr 2021 14:29:51 +0800</pubDate></item><item><title>Janssen公司受理号申报最多 | 药品审评进度周周看（3.29-4.4）</title><link>https://mp.weixin.qq.com/s/Dvps2CLc2D3qrr5WTV1OYw</link><description></description><content:encoded><![CDATA[Janssen公司受理号申报最多 | 药品审评进度周周看（3.29-4.4）]]></content:encoded><pubDate>Tue, 06 Apr 2021 15:50:44 +0800</pubDate></item><item><title>生物制品申报比例增加 | 药品审评进度周周看（3.22-3.28）</title><link>https://mp.weixin.qq.com/s/AuBYe38s6fQe_JI8zRNK9A</link><description></description><content:encoded><![CDATA[生物制品申报比例增加 | 药品审评进度周周看（3.22-3.28）]]></content:encoded><pubDate>Thu, 01 Apr 2021 12:01:12 +0800</pubDate></item><item><title>【开思系统数据更新】终端品类分析1月份数据更新上线！</title><link>https://mp.weixin.qq.com/s/cIop0G0AH1gaKxfFmpv0NA</link><description></description><content:encoded><![CDATA[【开思系统数据更新】终端品类分析1月份数据更新上线！]]></content:encoded><pubDate>Thu, 01 Apr 2021 12:01:12 +0800</pubDate></item><item><title>AstraZeneca公司受理号申报最多 | 药品审评进度周周看（3.15-3.21）</title><link>https://mp.weixin.qq.com/s/XTOiOlipQic9rGIThz0c7Q</link><description></description><content:encoded><![CDATA[AstraZeneca公司受理号申报最多 | 药品审评进度周周看（3.15-3.21）]]></content:encoded><pubDate>Mon, 22 Mar 2021 17:50:48 +0800</pubDate></item><item><title>【开思系统】保健品市场数据全新上线！</title><link>https://mp.weixin.qq.com/s/Ew3-GZMQOfYvAr2MVxHFmQ</link><description></description><content:encoded><![CDATA[【开思系统】保健品市场数据全新上线！]]></content:encoded><pubDate>Mon, 22 Mar 2021 17:50:48 +0800</pubDate></item><item><title>药捷安康新药受理号申报最多 | 药品审评进度周周看（3.8-3.14）</title><link>https://mp.weixin.qq.com/s/cR39o5c-3pVmahzeycAetA</link><description></description><content:encoded><![CDATA[药捷安康新药受理号申报最多 | 药品审评进度周周看（3.8-3.14）]]></content:encoded><pubDate>Mon, 15 Mar 2021 15:34:25 +0800</pubDate></item><item><title>广为医药新药受理号申报最多 | 药品审评进度周周看（3.1-3.7）</title><link>https://mp.weixin.qq.com/s/XsnUihdh-Il-rTi2PW6HjA</link><description></description><content:encoded><![CDATA[广为医药新药受理号申报最多 | 药品审评进度周周看（3.1-3.7）]]></content:encoded><pubDate>Mon, 08 Mar 2021 16:21:06 +0800</pubDate></item><item><title>新药申报比例上升 | 药品审评进度周周看（2.22-2.28）</title><link>https://mp.weixin.qq.com/s/7y2d5fMU9_m5VSf26lSHxA</link><description></description><content:encoded><![CDATA[新药申报比例上升 | 药品审评进度周周看（2.22-2.28）]]></content:encoded><pubDate>Mon, 01 Mar 2021 15:40:01 +0800</pubDate></item><item><title>【开思系统数据更新】2020年第四季度零售市场数据更新上线！</title><link>https://mp.weixin.qq.com/s/2-kUsMEMdGRRI-rtkeRzAg</link><description></description><content:encoded><![CDATA[【开思系统数据更新】2020年第四季度零售市场数据更新上线！]]></content:encoded><pubDate>Mon, 01 Mar 2021 15:40:01 +0800</pubDate></item><item><title>西安京西双鹤受理号申报最多 | 药品审评进度周周看（2.14-2.21）</title><link>https://mp.weixin.qq.com/s/lVqeIFuusrEgiDVVaK55OA</link><description></description><content:encoded><![CDATA[西安京西双鹤受理号申报最多 | 药品审评进度周周看（2.14-2.21）]]></content:encoded><pubDate>Mon, 22 Feb 2021 15:40:23 +0800</pubDate></item><item><title>中康CMH | 冰火两重天——栉风沐雨中毅行的药品零售市场解读</title><link>https://mp.weixin.qq.com/s/CaJL9SA64mERF6E7KgfrcQ</link><description></description><content:encoded><![CDATA[中康CMH | 冰火两重天——栉风沐雨中毅行的药品零售市场解读]]></content:encoded><pubDate>Mon, 22 Feb 2021 15:40:23 +0800</pubDate></item><item><title>科伦药业受理号申报最多 | 药品审评进度周周看（2.8-2.14）</title><link>https://mp.weixin.qq.com/s/3S8SYY2lBomDF5VbdA7IsA</link><description></description><content:encoded><![CDATA[科伦药业受理号申报最多 | 药品审评进度周周看（2.8-2.14）]]></content:encoded><pubDate>Fri, 19 Feb 2021 14:37:13 +0800</pubDate></item></channel></rss>